Wipfli Financial Advisors’s Novo Nordisk NVO Stock Holding History

Wipfli Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$651K	Buy	+13,068	New	+$700K	0.05%	176

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Wipfli Financial Advisors's NVO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Novo Nordisk (NVO) in Q3 2022: 13,068 shares worth $651K. The stake represents 0.05% of the portfolio and ranks #176 among its holdings.

907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

Wipfli Financial Advisors held 13,068 shares of Novo Nordisk worth $651K as of Q3 2022.
Novo Nordisk was a new Wipfli Financial Advisors position in Q3 2022.
Novo Nordisk made up 0.05% of Wipfli Financial Advisors's portfolio in Q3 2022, its #176 holding.
907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.